UPDATE : Monday, July 13, 2020
상단여백
‘Pfizer’s Vyndaqel, Vyndamax do not deserve rare disease pricing’
Pfizer’s Vyndaqel and Vyndamax -- containing tafamidis to treat cardiomyopa...
by Kim Yun-mi  |  2020-06-22 17:19
라인
New diabetes drug Steglatro fails to prove cardiovascular benefit
Steglatro (ingredient: ertugliflozin), the latecomer sodium-glucose co-tran...
by Kim Yun-mi  |  2020-06-19 14:55
라인
Yuyu to export SD Biosensor's Covid-19 test kit
Yuyu Pharmaceutical and SD Biosensor said they would cooperate in exporting...
by Lee Han-soo  |  2020-06-19 14:48
라인
HK inno.N nabs FDA nod for trial of gastric acid blocker
HK inno.N, formerly known as CJ Healthcare, said that the U.S. Food and Dru...
by Lee Han-soo  |  2020-06-18 17:39
라인
AZ’s Imfinzi wins extra indication for small-cell lung cancer
AstraZeneca’s immunotherapy Imfinzi (ingredient: durvalumab) has obtained l...
by Kim Yun-mi  |  2020-06-18 15:55
라인
5 key factors in successful secondary packaging and device assembly strategy
In his book The 7 Habits of Highly Effective People, Dr. Steven R. Covey of...
by Lee Han-soo  |  2020-06-18 15:52
라인
Lilly beats Pfizer in treating early breast cancer
Pfizer was the first to release a drug for the treatment of hormone recepto...
by Kim Yun-mi  |  2020-06-18 14:44
라인
‘Tecentriq, major turning point for triple-negative breast cancer treatment’
Roche Korea’s Tecentriq, the first immunotherapy to win indication for trip...
by Kim Yun-mi  |  2020-06-18 14:43
라인
IOF aims to reduce osteoporosis-related fractures by 25% by 2025
The International Osteoporosis Foundation, a non-governmental organization ...
by Kim Yun-mi  |  2020-06-17 14:28
라인
JW Pharma to recreate its anticancer therapy as Covid-19 drug
JW Pharmaceutical said Wednesday that it would reposition CWP291, its antic...
by Shim Hyun-tai  |  2020-06-17 14:26
라인
Sanofi releases hemophilia A treatment
Sanofi Aventis Korea said Tuesday that it was launching a hemophilia A trea...
by Shim Hyun-tai  |  2020-06-16 17:27
라인
Sillajen CEO steps down
Sillajen CEO Moon Eun-sang has resigned from his post.Moon’s resignation ca...
by Lee Han-soo  |  2020-06-16 16:49
라인
MSD fails to present plausible reasons, grounds for discriminating against branches
Last Thursday, MSD Korea's labor union took issue with the expanded imp...
by Lee Han-soo  |  2020-06-16 16:21
라인
Gemvax & Kael's GV1001 shows efficacy as hepatitis B treatment
Gemvax & Kael said that it has confirmed the efficacy of GV1001 in treating...
by Lee Han-soo  |  2020-06-16 16:18
라인
‘Celltrion has no reason to save Takeda Korea workers’ jobs’
Takeda Pharmaceutical’s sell-off of part of its business to Celltrion is ex...
by Kim Yun-mi  |  2020-06-16 11:44
라인
Jardiance family of diabetes drugs sells ₩10 billion in Q1
The Jardiance family of diabetes drugs, including Jardiance (empagliflozin)...
by Kim Yun-mi  |  2020-06-15 17:39
라인
Biogen’s FDA application for Alzheimer’s drug drags on
Biogen’s filing of aducanumab, an investigational Alzheimer’s drug, for U.S...
by Kim Yun-mi  |  2020-06-15 12:09
라인
Survey paints gloomy outlook for Korea’s developing Covid-19 treatment
About 60 percent of workers in the domestic pharmaceutical industry predict...
by Shim Hyun-tai  |  2020-06-12 17:56
라인
PharmAbcine inks CDMO deal with Australian firm for immunotherapy candidate
PharmAbcine, an antibody new drug developer, has signed a CDMO (contract de...
by Lee Han-soo  |  2020-06-12 17:15
라인
Regulators OKs Pharmicell’s P2 trial of erectile dysfunction treatment
Pharmicell said that the Ministry of Food and Drug Safety has approved its ...
by Lee Han-soo  |  2020-06-12 16:07
여백
여백
여백
Back to Top